Back
Innate Pharma SA Stock Price Chart
Sponsored
IPHA
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
IPHA
Innate Pharma SA
Last Price:
1.45
Seasonality Move:
6.04%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing selling pressure, which indicates risk of future bearish movement.
Innate Pharma SA Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.6 | Buy |
20-day SMA: | 1.75 | Sell |
50-day SMA: | 1.97 | Sell |
200-day SMA: | 2.3 | Sell |
8-day EMA: | 1.65 | Sell |
20-day EMA: | 1.74 | Sell |
50-day EMA: | 1.91 | Sell |
200-day EMA: | 2.24 | Sell |
Innate Pharma SA Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 42.81 | Sell |
Chaikin Money Flow: | 999 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Innate Pharma SA Technical Analysis
Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Innate Pharma SA Stock
Is Innate Pharma SA Stock a Buy?
- Innate Pharma SA share price is 1.63 while IPHA 8-day simple moving average is 1.60, which is a Buy signal.
- The stock price of IPHA is 1.63 while Innate Pharma SA 20-day SMA is 1.75, which makes it a Sell.
- Innate Pharma SA 50-day simple moving average is 1.97 while IPHA share price is 1.63, making it a Sell technically.
- IPHA stock price is 1.63 and Innate Pharma SA 200-day simple moving average is 2.30, creating a Sell signal.
IPHA Technical Analysis vs Fundamental Analysis
Sell
27
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy or a Sell?
-
Innate Pharma SA stock is rated a Sell
The current Innate Pharma SA [IPHA] share price is $1.63. The Score for IPHA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Innate Pharma SA Stock Info
Market Cap:
131.95M
Price in USD:
1.63
Share Volume:
7.99K
Innate Pharma SA 52-Week Range
52-Week High:
3.15
52-Week Low:
1.29
Sell
27
Innate Pharma SA (IPHA)
is a Sell
Innate Pharma SA Share Price Forecast
-
What is the Innate Pharma SA stock price today?
The Innate Pharma SA stock price is 1.63 USD today. -
Will IPHA stock go up or go down?
Innate Pharma SA> share price is forecast to RISE/FALL based on technical indicators -
Is Innate Pharma SA overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Innate Pharma SA is overvalued.
Is Innate Pharma SA Stock a Buy?
- Innate Pharma SA share price is 1.63 while IPHA 8-day exponential moving average is 1.65, which is a Sell signal.
- The stock price of IPHA is 1.63 while Innate Pharma SA 20-day EMA is 1.74, which makes it a Sell.
- Innate Pharma SA 50-day exponential moving average is 1.91 while IPHA share price is 1.63, making it a Sell technically.
- IPHA stock price is 1.63 and Innate Pharma SA 200-day simple moving average is 2.24, creating a Sell signal.
Fundamental Analysis of Innate Pharma SA
Is Innate Pharma SA a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Innate Pharma SA
Should I short Innate Pharma SA stock?
- IPHA Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Innate Pharma SA is a Sell
- Innate Pharma SA Relative Strength Index (RSI) is 42.81, which suggest Innate Pharma SA is oversold
- The Bollinger Bands (25) for Innate Pharma SA is ( - ), which suggest Innate Pharma SA is a Buy
- The Bollinger Bands (100) for Innate Pharma SA is ( - ), which suggest Innate Pharma SA is a Buy
* Innate Pharma SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.